BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $4.25 | Prev. Close $4.40 | Circuit Range N/A |
Day Range $4.25 - $4.54 | Year Range $0.61 - $13.78 | Volume 4,862 |
Average Traded $4.45 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $4.16 | $4.34 | -4.30% |
17-Mar-26 | $4.44 | $4.54 | +3.89% |
16-Mar-26 | $4.31 | $4.37 | +3.68% |
13-Mar-26 | $4.28 | $4.21 | -1.52% |
12-Mar-26 | $4.20 | $4.28 | -1.27% |
11-Mar-26 | $3.89 | $4.33 | +13.95% |
10-Mar-26 | $3.91 | $3.80 | +1.74% |